Xiaoqi Zeng
No.1838 North Guangzhou Avenue
Guangzhou, 510515, China
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
FRAX486, a PAK inhibitor, overcomes ABCB1-mediated multidrug resistance in breast cancer cells.
Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica
Published: February 28, 2024
Prevalence of breast fibroadenoma in healthy physical examination population in Guangdong province of China: a cross-sectional study.
Journal: BMJ open
Published: June 27, 2022
Methylated biomarkers for breast cancer identified through public database analysis and plasma target capture sequencing.
Journal: Annals of translational medicine
Published: May 14, 2021
MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple‑negative breast cancer cells.
Journal: Molecular medicine reports
Published: December 14, 2020
Cardiovascular risk factors and breast cancer incidence in a large middle-aged cohort study.
Journal: BMC cancer
Published: November 12, 2020
The miR-1185-2-3p-GOLPH3L pathway promotes glucose metabolism in breast cancer by stabilizing p53-induced SERPINE1.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 17, 2020
High Quality Plasmonic Sensors Based on Fano Resonances Created through Cascading Double Asymmetric Cavities.
Journal: Sensors (Basel, Switzerland)
Published: August 17, 2016
miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
Journal: International journal of molecular medicine
Published: April 04, 2015
Long noncoding RNA aberrant expression profiles after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of AGC ascertained by microarray analysis.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 23, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026